WALTHAM, Mass., Feb. 6, 2013 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO) announced today that Lonnie Moulder, Chief Executive Officer, and Mary Lynne Hedley, Ph.D., President and Chief Scientific Officer, will present at the Leerink Swann Global Healthcare Conference at the Waldorf Astoria Hotel in New York on Thursday, February 14, 2013 at 11:00 a.m. EST.
Interested parties may access a live audio webcast of the presentation via the investors section of the TESARO website, www.tesarobio.com. A replay of the webcast will be archived on the TESARO website for 14 days.
TESARO, Inc. is an oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients.
The TESARO, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=13456
CONTACT: Richard Rodgers Executive Vice President & CFO +1.339.970.0903 firstname.lastname@example.org